The vitamin D-vitamin D receptor axis in uterine leiomyomas: A scoping review of clinical, molecular, and genetic evidence

Uterine leiomyomas are the most common benign tumours of the female reproductive tract and a major cause of gynaecological morbidity worldwide. Observational and experimental studies have linked vitamin D and the vitamin D receptor (VDR) separately to uterine leiomyoma biology, including effects on cell proliferation and Wnt/β-catenin signalling in vitro; however, the breadth of this evidence has not been comprehensively mapped across clinical, molecular, and genetic domains. We conducted a scoping review following Joanna Briggs Institute (JBI) methodology and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 2016 to December 2025. Forty-two studies were included: 31 clinical, seven molecular, and four genetic. Most clinical studies reported lower circulating 25-hydroxyvitamin D concentrations among women with uterine leiomyomas compared with controls, with several demonstrating inverse associations with fibroid size, volume, or number; however, fewer than half adjusted for BMI and only one study adjusted for ethnicity, limiting causal inference. Seven molecular studies examined the vitamin D-VDR axis in leiomyoma tissue and cells: three demonstrated reduced VDR expression, two demonstrated upregulated CYP24A1 expression, and two demonstrated calcitriol-mediated suppression of Wnt/β-catenin signalling (and, in one study, mTOR signalling). Four genetic studies showed inconsistent associations between VDR and vitamin D metabolism gene polymorphisms and leiomyoma susceptibility across populations. The evidence maps parallel associations of lower circulating vitamin D, lower VDR expression and higher CYP24A1 expression in leiomyoma tissue with the disease; no included study tested whether VDR mediates or modifies the relationship between vitamin D and leiomyoma. Findings remain heterogeneous and largely observational. Well-designed prospective cohort studies incorporating LC-MS/MS vitamin D measurement, concurrent tissue sampling, and full confounder adjustment are needed to clarify the clinical and mechanistic significance of this pathway.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-18
DOI
https://doi.org/10.1371/journal.pone.0363360
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The vitamin D-vitamin D receptor axis in uterine leiomyomas: A scoping review of clinical, molecular, and genetic evidence

Agnes Namaganda, Haruna Muwonge, Hamson Kanyesigye, Godfrey Katamba et al.
PLoS ONE
Uterine Myomas and Treatments
article

The vitamin D-vitamin D receptor axis in uterine leiomyomas: A scoping review of clinical, molecular, and genetic evidence

Agnes Namaganda, Haruna Muwonge, Hamson Kanyesigye, Godfrey Katamba, David Collins Agaba, Rogers Kajabwangu, Mivule A. Kinene, Ronald Ouma Omolo
article en

Abstract

Uterine leiomyomas are the most common benign tumours of the female reproductive tract and a major cause of gynaecological morbidity worldwide. Observational and experimental studies have linked vitamin D and the vitamin D receptor (VDR) separately to uterine leiomyoma biology, including effects on cell proliferation and Wnt/β-catenin signalling in vitro; however, the breadth of this evidence has not been comprehensively mapped across clinical, molecular, and genetic domains. We conducted a scoping review following Joanna Briggs Institute (JBI) methodology and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 2016 to December 2025. Forty-two studies were included: 31 clinical, seven molecular, and four genetic. Most clinical studies reported lower circulating 25-hydroxyvitamin D concentrations among women with uterine leiomyomas compared with controls, with several demonstrating inverse associations with fibroid size, volume, or number; however, fewer than half adjusted for BMI and only one study adjusted for ethnicity, limiting causal inference. Seven molecular studies examined the vitamin D-VDR axis in leiomyoma tissue and cells: three demonstrated reduced VDR expression, two demonstrated upregulated CYP24A1 expression, and two demonstrated calcitriol-mediated suppression of Wnt/β-catenin signalling (and, in one study, mTOR signalling). Four genetic studies showed inconsistent associations between VDR and vitamin D metabolism gene polymorphisms and leiomyoma susceptibility across populations. The evidence maps parallel associations of lower circulating vitamin D, lower VDR expression and higher CYP24A1 expression in leiomyoma tissue with the disease; no included study tested whether VDR mediates or modifies the relationship between vitamin D and leiomyoma. Findings remain heterogeneous and largely observational. Well-designed prospective cohort studies incorporating LC-MS/MS vitamin D measurement, concurrent tissue sampling, and full confounder adjustment are needed to clarify the clinical and mechanistic significance of this pathway.

PLoS ONEVol. 21(11)
Mbarara University of Science and Technology (UG), King Ceasor University (UG), Makerere University (UG)
Uterine Myomas and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon